Catheter-directed Sclerotherapy Versus Surgical Resecction: Randomized Controlled Trial Comparing Ovarian Function and Therapeutic Efficacy After Treatment of Ovarian Endometrioma

Overview

The primary purpose of this study is to compare residual ovarian function and therapeutic efficacy of surgical resection and catheter-directed sclerotherapy for ovarian endometrioma

Screening * History, Physical examination * Vital signs * Laboratory test (Serum AMH, CA-125, HE-4) / EKG / MRI * EHP-30 Intervention * Surgical enucleation or catheter-directed sclerotherapy * Laboratory test / EKG * Adverse event monitoring Follow-up visit #1 (1 month) * Vital signs * Lab test (AMH, CA-125) / Ultrasound * Adverse event monitoring Follow-up visit #2 (6 months) * Vital signs * Lab test (AMH, CA-125) / Ultrasound / Contrast-enhanced MRI * EHP-30 Follow-up visit #3 (12months) * Vital signs * Lab test (AMH, CA-125) / Ultrasound * EHP-30

Conditions

Interventions

Eligibility

Locations (1)

Outcomes

Central Contacts